Research / FFIV / Fundamental state Inspectable configuration
State dimensions Filing 0001048695-22-000015 General Corporate
Debt relative to revenue 38th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.debt_to_revenue
56.67% · OPTIONAL · VALID
Capex intensity 11th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.82% · OPTIONAL · VALID
Operating cash generation 22th Own-history percentile · N=9
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
19.95% · OPTIONAL · VALID
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
-1.71% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure 67th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
4.40% · OPTIONAL · VALID
Gross margin 11th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.gross_margin
80.08% · CORE · VALID
Operating margin 11th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.operating_margin
11.77% · CORE · VALID
R&D intensity 89th Own-history percentile · N=9
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
21.42% · OPTIONAL · VALID
SBC intensity 100th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
10.11% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 27 states Self-history eligible
Sep 30, 2021 0/9 normalized Level 3 Dec 31, 2021 7/9 normalized Level 3 Mar 31, 2022 8/9 normalized Level 3 Jun 30, 2022 8/9 normalized Level 3 Sep 30, 2022 8/9 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 8/8 normalized Level 3 Jun 30, 2024 8/8 normalized Level 3 Sep 30, 2024 8/8 normalized Level 3 Dec 31, 2024 8/8 normalized Level 3 Mar 31, 2025 8/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 8/8 normalized Level 3 Dec 31, 2025 8/8 normalized Level 3 Mar 31, 2026 8/8 normalized Level 3 Jun 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 53.01%
Current 56.67%
Delta 3.66% Capex Intensity Decreased
Previous 1.54%
Current 0.82%
Delta -0.71% Cash Generation Increased
Previous 13.15%
Current 19.95%
Delta 6.80% Growth Decreased
Previous 10.00%
Current -1.71%
Delta -11.72% Inventory Pressure Increased
Previous 3.03%
Current 4.40%
Delta 1.37% Margin Decreased
Previous 80.34%
Current 80.08%
Delta -0.27% Profitability Decreased
Previous 16.61%
Current 11.77%
Delta -4.84% R And D Intensity Increased
Previous 18.96%
Current 21.42%
Delta 2.46% Sbc Intensity Increased
Previous 9.28%
Current 10.11%
Delta 0.83% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.